To download a PDF of this CME article, click here.To start this activity, click Begin at the bottom of this page
Release Date: May 2012
Expiration Date: May 2013
Continue Reading
Estimated time to complete the educational activity: 1 hour
This activity is jointly sponsored by Medical Education Resources and Haymarket Medical Education and is supported by an educational grant from Allergan, Inc.
Statement of Need: Urologists and other healthcare professionals caring for patients with bladder dysfunction should be knowledgeable about the symptoms of neurogenic bladder (NGB) and integrate assessment and diagnostic approaches that may facilitate identification of patients for earlier treatment. Providers should also be knowledgeable about the various treatment options for NGB, including options for patients who fail behavioral or oral therapy.
Target Audience: This activity has been designed to meet the educational needs ofurologists and other clinicians involved in the treatment of patients with bladder dysfunction.
Educational Objectives: After completing the activity, the participant should be better able to:
• Identify patients for individualized treatment earlier using diagnostic strategies.
• Describe management options for neurogenic bladder, including evidence-based treatments and novel therapeutic approaches.
Accreditation Statement:This activity has been planned and implemented inaccordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Resources (MER) and Haymarket Medical Education. MER is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: Medical Education Resources designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest: Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all its educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in health care and not a commercial interest.
| Name of Faculty | Reported Financial Relationship |
| David A. Ginsberg, MD | Grants/Research Support: Allergan, Inc., Medtronic, Inc. Consultant: Allergan, Inc., American Medical Systems, Inc. Speakers’ Bureau: Allergan, Inc., Pfizer, Inc. |
The content managers, Roxanne Nelson, RN, Mary Jo Krey, Lori Marrese, Jody A. Charnow, and Marina Galanakis of Haymarket Medical Education, and Victoria C. Smith, MD, of Medical Education Resources, have disclosed that they have no relevant financial relationships or conflicts of interest.
Method of Participation: There are no fees for participating in and receiving CME credit for this activity. During the period May 2012 through May 2013, participants must: 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest and submit it online. Physicians may register at www.myCME.com/renalandurologynews, and 4) complete the evaluation form online.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better.
